Written and maintained by CASRAI Editorial Board
Last updated
Short answer
The classical complement pathway is the branch of the complement system that starts when the C1 complex (C1q with C1r and C1s) recognizes antibody bound to an antigen. Activated C1s cleaves C4 and C2 to form the C3 convertase C4b2a, which leads to a C5 convertase and the membrane attack complex. Antibody is the usual trigger, but not the only one.
Definition and scope
The Medical Subject Headings (MeSH) entry “Complement Pathway, Classical” describes the pathway as one in which C1 binds antigen-antibody complexes through C1q, then C1r and C1s are activated in sequence. MeSH also lists the alternative names Classical Complement Pathway, Complement Activation Pathway, Classical, and Classical Complement Activation Pathway. These are the same concept, which is useful when searching the literature for the “complement cascade classical pathway” or the “complement pathway classical”.
The classical pathway is one of three activation routes of the complement system, a set of plasma proteins that is part of the immune system. This guide covers the classical route, how it compares with the lectin and alternative routes, and what a defect in its components looks like. It is general reference information, not individual medical advice, and it does not describe any laboratory procedure. For the wider field, see what immunology is.
How the classical pathway is activated
Recognition: C1q, C1r and C1s
According to the Merck Manual Professional, C1 binds antigen-IgM complexes or aggregated antigen-IgG complexes. C1q is the recognition component. A 2019 review in Frontiers in Immunology (Carpanini, Torvell and Morgan) states it the same way: the classical pathway is activated through antibody/antigen recognition by C1q in complex with C1r and C1s.
Cleavage of C4 and C2, then convergence
Per MeSH, activated C1s cleaves C4 and C2, producing the classical C3 convertase, written C4b2a. That enzyme goes on to form the C5 convertase (C4b2a3b), which cleaves C5 and leads to assembly of the membrane attack complex. The Merck Manual describes the shared end of all three pathways: a C3 convertase cleaves C3 into C3a and C3b, a C5 convertase follows, and the membrane attack complex (C5b to C9) forms transmembrane pores that cause osmotic lysis of susceptible cells.
Antibody-independent triggers
The Merck Manual also lists classical-pathway triggers that do not need antibody: polyanions, gram-negative bacteria and bound C-reactive protein.
Classical, lectin and alternative pathways compared
The table below summarizes triggers and named regulators for each route, from the Merck Manual Professional and Carpanini et al.
| Pathway | What starts it | Antibody required? | Regulators named in the sources |
|---|---|---|---|
| Classical | C1 binding antigen-IgM or aggregated antigen-IgG complexes; also polyanions, gram-negative bacteria, bound C-reactive protein | Usually, but antibody-independent triggers exist | C1 inhibitor |
| Lectin | Mannose-binding lectin binding carbohydrates on bacterial or yeast walls and some viruses | No | C1 inhibitor (Carpanini et al.) |
| Alternative | Always somewhat active; driven by microbial surface molecules such as endotoxin, and by aggregated IgA | No | Properdin, factor H, DAF (CD55) |
The Merck Manual notes that after the initial binding, the lectin pathway closely resembles the classical pathway. Carpanini et al. add that classical and lectin convertases converge with the alternative pathway at the central C3 and C5 convertases, and that C1 inhibitor prevents excessive activation of both the classical and lectin pathways. The same review names CR1, C4BP, DAF, MCP and factor I as regulators acting on C3 convertases. The alternative pathway is covered here only for contrast; the alternative complement pathway has its own triggers and regulators as shown.
Where it matters for labs and clinics
Complement biology appears in laboratory and clinical settings mainly through what happens when a component is missing or poorly regulated. The Merck Manual links the following to classical-pathway components and their regulator:
| Component or regulator | Associated condition per Merck Manual |
|---|---|
| C1 or C2 deficiency | Recurrent bacterial infections |
| C1, C4 or C5 defects | Systemic lupus erythematosus (SLE) |
| C1 inhibitor deficiency or dysfunction | Hereditary angioedema |
The same source lists deficiencies in C3, mannose-binding lectin, MASP-2, factor H, factor I and CR2 with recurrent bacterial infections, and in C5, C9, factor B, factor D and properdin with neisserial infections. Those fall outside the classical-only scope but show why a missing component is described by which part of the cascade it affects. Diagnosis and management of any such condition belong with a clinician.
For researchers who work with antibodies, the pathway is a reminder that bound antibody can do more than label a target: IgM and aggregated IgG are the complexes the Merck Manual names as C1 binders. Antibody-based methods are covered in separate CASRAI guides, including ELISA basics, immunohistochemistry controls and co-immunoprecipitation controls.
Common misunderstandings
“The classical pathway always needs antibody.”
Antibody-antigen complexes are the main trigger, but the Merck Manual lists polyanions, gram-negative bacteria and bound C-reactive protein as antibody-independent classical triggers.
“The three pathways are separate systems.”
They differ in how they start. Per the Merck Manual they converge when a C3 convertase cleaves C3, and all lead to the membrane attack complex.
“Complement only kills bacteria.”
Lysis through the membrane attack complex is one outcome. Carpanini et al. also review complement activity in the nervous system, where most of the evidence is from rodent studies and is sometimes contradictory, so it should not be read as settled human biology.
FAQ
What is the complement system?
It is a set of plasma proteins in the immune system that can be activated by the classical, lectin or alternative pathway. All three converge on C3 cleavage and can end in the membrane attack complex (Merck Manual Professional).
What is the function of the complement system?
Complement defends against infection; one outcome is lysis of susceptible cells through the membrane attack complex, and the Merck Manual links defects to infections and to autoimmune and other disorders.
What are the complement proteins in the immune system?
Classical-pathway proteins named above are C1q, C1r, C1s, C4 and C2, then C3, C5 and C5b to C9. Regulators named include C1 inhibitor, properdin, factor H, DAF (CD55), CR1, C4BP, MCP and factor I.
What is the difference between the classical and alternative complement pathway?
The classical pathway is usually triggered by antibody-antigen complexes bound by C1. The alternative pathway is always somewhat active and is driven by microbial surface molecules and aggregated IgA, with properdin, factor H and DAF as regulators.
Sources
- Merck Manual Professional Edition, “Complement System”: https://www.merckmanuals.com/professional/immunology-allergic-disorders/biology-of-the-immune-system/complement-system (checked 2026-10-29).
- National Library of Medicine, MeSH descriptor D003171, “Complement Pathway, Classical”: https://www.ncbi.nlm.nih.gov/mesh/68003171 (checked 2026-10-29).
- Carpanini SM, Torvell M, Morgan BP. Front Immunol 2019;10:362. https://doi.org/10.3389/fimmu.2019.00362 (checked 2026-10-29).
